Drug development in oncology is historically challenging, exhibiting a very high attrition rate, with low rates of approval for novel treatments when compared to other therapeutic areas. At present, ...
The Rhode Island Life Science Hub announced today that it has awarded $128,810 in grants to fourteen different organizations in the state. This second round of funding aims to bolster Rhode Island’s ...
From manufacturing vital drugs to driving research to raising funds and awareness, leaders like AstraZeneca, Ford and Estée Lauder are having an impact ...